Literature DB >> 3902125

Epidemiology and endocrinology of benign breast disease.

D Y Wang, I S Fentiman.   

Abstract

Entities:  

Keywords:  Age Factors; Androgens; Biology; Body Weight; Breast Cancer--etiology; Breast Cancer--prevention and control; Cancer; Contraception; Contraceptive Methods; Cultural Background; Demographic Factors; Diseases; Economic Factors; Endocrine Effects; Endocrine System; Epidemiologic Methods; Estrogens; Ethnic Groups; Family Planning; Hormones; Literature Review; Neoplasms; Obesity; Oral Contraceptives; Physiology; Pituitary Hormones; Population; Population At Risk; Population Characteristics; Progestational Hormones; Progesterone; Prolactin; Prostaglandins; Reproduction; Research Methodology; Socioeconomic Factors; Socioeconomic Status

Mesh：

Substances：

Year:  1985        PMID： 3902125     DOI： 10.1007/bf01806008

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  182 in total

1.  DIRECT PERIPHERAL CONVERSION OF DEHYDROEPIANDROSTERONE TO TESTOSTERONE GLUCURONOSIDE.

Authors:  S G KORENMAN; M B LIPSETT
Journal:  Steroids       Date:  1965-04       Impact factor: 2.668

2.  Urinary and plasma androgens in benign breast disease. Possible relation to breast cancer.

Authors:  M J Brennan; D Y Wang; J L Hayward; R D Bulbrook; N Deshpande
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

3.  A specific progesterone-binding component of human breast cyst fluid.

Authors:  W H Pearlman; J L Guériguian; M E Sawyer
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

4.  Risk factors for benign breast disease: a 30-year cohort study.

Authors:  T G Hislop; J M Elwood
Journal:  Can Med Assoc J       Date:  1981-02-01       Impact factor: 8.262

5.  Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls.

Authors:  J W Moore; G M Clark; R D Bulbrook; J L Hayward; J T Murai; G L Hammond; P K Siiteri
Journal:  Int J Cancer       Date:  1982-01-15       Impact factor: 7.396

6.  Detection of alpha-lactalbumin in breast lesions and relationship to estrogen receptors and serum prolactin.

Authors:  R M Bahu; M Mangkornkanok-Mark; D Albertson; E Fors; A Molteni; H Battifora
Journal:  Cancer       Date:  1980-10-15       Impact factor: 6.860

7.  Benign breast disease and oral contraceptive use.

Authors:  D T Janerich; D M Glebatis; J M Dugan
Journal:  JAMA       Date:  1977-05-16       Impact factor: 56.272

8.  [Prolactin in pathology of the breast. Clinical study ].

Authors:  M Latteri; G Bajardi; C Castiglione; F Caronia; S Maragliano; A Briganti; S Latteri; L Bellanca
Journal:  Minerva Med       Date:  1980-07       Impact factor: 4.806

9.  Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer.

Authors:  D Y Wang; J L Hayward; R D Bulbrook
Journal:  Eur J Cancer       Date:  1966-12       Impact factor: 9.162

10.  Correlation between levels of dehydroepiandrosterone-sulphate and prolactin in human breast cyst fluid.

Authors:  A Angeli; G Boccuzzi; F Agrimonti; E Brignardello; E Barbadoro; L Dogliotti
Journal:  Tumori       Date:  1982-10-31
View more
  30 in total

1.  The luteal heat cycle of the breast in disease.

Authors:  H W Simpson; K Griffiths; C McArdle; A W Pauson; P Hume; A Turkes
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Absence of in vitro mutagenicity of the fluid from breast cysts of women with macrocystic disease.

Authors:  I I Arzimanoglou; C E Sekeris; S Vassilaros
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Factors Effecting Mastalgia.

Authors:  Tunc Eren; Adem Aslan; Ibrahim A Ozemir; Hakan Baysal; Julide Sagiroglu; Ozgur Ekinci; Orhan Alimoglu
Journal:  Breast Care (Basel)       Date:  2016-03-29       Impact factor: 2.860

4.  Alcoholic beverage consumption and risk of breast cancer in Spain.

Authors:  J M Martin-Moreno; P Boyle; L Gorgojo; W C Willett; J Gonzalez; F Villar; P Maisonneuve
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

5.  Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease.

Authors:  C Panahy; J R Puddefoot; E Anderson; G P Vinson; C L Berry; M J Turner; C L Brown; A W Goode
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-22

6.  Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.

Authors:  I H Russo; J Frederick; J Russo
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

7.  A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.

Authors:  Thomas E Rohan; Abdissa Negassa; Rowan T Chlebowski; Clementina D Ceria-Ulep; Barbara B Cochrane; Dorothy S Lane; Mindy Ginsberg; Sylvia Wassertheil-Smoller; David L Page
Journal:  Breast Cancer Res Treat       Date:  2008-10-14       Impact factor: 4.872

8.  beta-Glucuronidase levels in patients with fibrocystic breast disease.

Authors:  J P Minton; Z Walaszek; W Schooley; M Hanausek-Walaszek; T E Webb
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

9.  Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors.

Authors:  Teresa A Rose-Hellekant; Andrew J Skildum; Olga Zhdankin; Amy L Greene; Ronald R Regal; Katherine D Kundel; Donald W Kundel
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28

10.  Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.

Authors:  R J Lellé; W Heidenreich; G Stauch; I Wecke; J Gerdes
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.